CLDX(Celldex Therapeutics, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $4.65M | $2.36M | $6.88M | $7.02M | $1.54M |
| 毛利润 | $4.55M | $2.26M | $6.58M | $6.82M | $1.34M |
| 营业利润 | −$71.24M | −$115.23M | −$154.54M | −$195.08M | −$287.37M |
| 净利润 | −$70.51M | −$112.33M | −$141.43M | −$157.86M | −$258.76M |
| 经营现金流 | −$60.91M | −$103.73M | −$107.29M | −$157.78M | −$210.94M |
| 自由现金流 | −$62.16M | −$105.56M | −$109.11M | −$159.70M | −$213.66M |
| 摊薄每股收益 | $-1.64 | $-2.40 | $-2.92 | $-2.45 | $-3.90 |